Antitumor Effects of Intravenous Natural Killer Cell Infusion in an Orthotopic Glioblastoma Xenograft Murine Model and Gene Expression Profile Analysis
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25042435 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Takayuki Morimoto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Nara Medical University, Kashihara 634-8521, Nara, Japan. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Despite standard multimodality treatment, containing maximum safety resection, temozolomide, radiotherapy, and a tumor-treating field, patients with glioblastoma (GBM) present with a dismal prognosis. Natural killer cell (NKC)-based immunotherapy would play a critical role in GBM treatment. We have previously reported highly activated and ex vivo expanded NK cells derived from human peripheral blood, which exhibited anti-tumor effect against GBM cells. Here, we performed preclinical evaluation of the NK cells using an in vivo orthotopic xenograft model, the U87MG cell-derived brain tumor in NOD/Shi-scid, IL-2RɤKO (NOG) mouse. In the orthotopic xenograft model, the retro-orbital venous injection of NK cells prolonged overall survival of the NOG mouse, indirectly indicating the growth-inhibition effect of NK cells. In addition, we comprehensively summarized the differentially expressed genes, especially focusing on the expression of the NKC-activating receptors’ ligands, inhibitory receptors’ ligands, chemokines, and chemokine receptors, between murine brain tumor treated with NKCs and with no agents, by using microarray. Furthermore, we also performed differentially expressed gene analysis between an internal and external brain tumor in the orthotopic xenograft model. Our findings could provide pivotal information for the NK-cell-based immunotherapy for patients with GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Nara Medical University, Kashihara 634-8521, Nara, Japan.
- Department of Neurosurgery, Nara City Hospital, Nara 630-8305, Nara, Japan.
- Grandsoul Research Institute for Immunology, Inc., Uda 633-2221, Nara, Japan.
ORCID-Profile: Takayuki Morimoto, Tsutomu Nakazawa, Ryosuke Matsuda, Ryosuke Maeoka, Mitsutoshi Nakamura, Shuichi Yamada, Ichiro Nakagawa
Zitieren
APA
Morimoto, T., Nakazawa, T., Matsuda, R., Maeoka, R., Nishimura, F., Nakamura, M., Yamada, S., Park, Y. S., Tsujimura, T., & Nakagawa, I. (2024). Antitumor Effects of Intravenous Natural Killer Cell Infusion in an Orthotopic Glioblastoma Xenograft Murine Model and Gene Expression Profile Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25042435
Vancouver
Morimoto T, Nakazawa T, Matsuda R, Maeoka R, Nishimura F, Nakamura M, et al. Antitumor Effects of Intravenous Natural Killer Cell Infusion in an Orthotopic Glioblastoma Xenograft Murine Model and Gene Expression Profile Analysis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25042435
BibTeX
@article{Morimoto2024,
author = {Morimoto, Takayuki and Nakazawa, Tsutomu and Matsuda, Ryosuke and Maeoka, Ryosuke and Nishimura, Fumihiko and Nakamura, Mitsutoshi and Yamada, Shuichi and Park, Young-Soo and Tsujimura, Takahiro and Nakagawa, Ichiro},
title = {Antitumor Effects of Intravenous Natural Killer Cell Infusion in an Orthotopic Glioblastoma Xenograft Murine Model and Gene Expression Profile Analysis},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25042435}
}
EUVIMED